Rhodes Jason P's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Aug 17, 2026
- Accession no.
- 0001577014-26-000016
- Filed
- Aug 17, 2026, 5:30 PM ET
- Trade date
- Aug 13-14, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $65.2M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhodes Jason PCIK 0001577014 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | SSaleDisposed | −268,354 | $26.20 | −$7,030,874.8 | 3,801,128 | Indirect | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −94,415 | $26.20 | −$2,473,673 | 1,045,735 | Indirect | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −63,643 | $26.20 | −$1,667,446.6 | 751,411 | Indirect | |
| Aug 14, 2026 | Common Stock | SSaleDisposed | −1,359,674 | $25.00 | −$33,991,850 | 2,441,454 | Indirect | |
| Aug 14, 2026 | Common Stock | SSaleDisposed | −478,377 | $25.00 | −$11,959,425 | 567,358 | Indirect | |
| Aug 14, 2026 | Common Stock | SSaleDisposed | −322,465 | $25.00 | −$8,061,625 | 428,946 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.